(Q44141797)

English

A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck

scientific article published in October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

phase II clinical trial

0 references

phase I clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Roy B Tishler

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Charles M Norris

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

A Dimitrios Colevas

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Carolyn C Lamb

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Daniel Karp

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Paul M Busse

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Asa Nixon

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Robert Frankenthaler

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Bernadette Lake-Willcutt

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Rosemary Costello

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Maryann Case

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Marshall R Posner

12

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1472-1481

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tête et du Cou (GETTEC)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. The Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

A phase I trial of 96-hour paclitaxel infusion plus accelerated radiotherapy of unrespectable head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Phase I study of docetaxel with concomitant thoracic radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Docetaxel: an active drug for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

21 January 2018

Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer: an Eastern Cooperative Oncology Group pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiotherapy and concomitant weekly 1-hour infusion of paclitaxel in the treatment of head and neck cancer--results from a Phase I trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro studies of Taxol as a radiation sensitizer in human tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10873

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.10873

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44141797&oldid=2107061914"